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Background: In plants and photosynthetic bacteria, the tyrosine degradation
pathway is crucial because homogentisate, a tyrosine degradation product, is a
precursor for the biosynthesis of photosynthetic pigments, such as quinones or
tocophenols. Homogentisate biosynthesis includes a decarboxylation step, a
dioxygenation and a rearrangement of the pyruvate sidechain. This complex reaction
is carried out by a single enzyme, the 4-hydroxyphenylpyruvate dioxygenase
(HPPD), a non-heme iron dependent enzyme that is active as a homotetramer in
bacteria and as a homodimer in plants. Moreover, in humans, a HPPD deficiency is
found to be related to tyrosinemia, a rare hereditary disorder of tyrosine catabolism. 
Results: We report here the crystal structure of Pseudomonas fluorescens HPPD
refined to 2.4 Å resolution (Rfree 27.6%; R factor 21.9%). The general topology of
the protein comprises two barrel-shaped domains and is similar to the structures
of Pseudomonas 2,3-dihydroxybiphenyl dioxygenase (DHBD) and Pseudomonas
putida catechol 2,3-dioxygenase (MPC). Each structural domain contains two
repeated βαβββα modules. There is one non-heme iron atom per monomer
liganded to the sidechains of His161, His240, Glu322 and one acetate molecule. 
Conclusions: The analysis of the HPPD structure and its superposition with the
structures of DHBD and MPC highlight some important differences in the active
sites of these enzymes. These comparisons also suggest that the pyruvate part
of the HPPD substrate (4-hydroxyphenylpyruvate) and the O2 molecule would
occupy the three free coordination sites of the catalytic iron atom. This
substrate–enzyme model will aid the design of new inhibitors of the
homogentisate biosynthesis reaction.
Introduction
4-Hydroxyphenylpyruvic acid dioxygenase (HPPD; EC
1.13.11.27) participates in tyrosine catabolism. The L-tyro-
sine is first transformed into 4-hydroxyphenylpyruvate
(HPP) by tyrosine aminotransferase (EC 2.6.1.5); then, in
a second step, HPPD catalyzes the formation of homogen-
tisate from HPP. Homogentisate is then degraded and
eliminated by its incorporation into the Krebs cycle. The
biosynthesis of the homogentisate molecule involves three
steps: the decarboxylation of the pyruvate sidechain, the
incorporation of molecular oxygen, and the rearrangement
of the resulting sidechain. During the reaction, one O2
molecule is incorporated at positions C1 and C8 of HPP
and one CO2 molecule is released as the first product
(Figure 1). This reaction is iron dependent and the
enzyme activity requires a non-heme Fe2+ atom [1].
HPPD is found in all types of organism. Its gene has
already been identified and/or expressed for several mam-
malian species (human [2–4], mouse [5,6], rat [7] and pig
[8]) as well as plants (Arabidopsis thaliana [9] and carrot
[10]), fungi [11] and procaryotes (Pseudomonas [12] and
Streptomyces avermitilis [13]). In eucaryotes, HPPD is active
as a homodimer of 45 kDa subunits, whereas the bacterial
enzyme is a homotetramer of 40 kDa subunits. 
In plants, the HPPD reaction product, homogentisate, is a
precursor of plastoquinones and tocopherols. Plasto-
quinones have been proposed as cofactors for phytoene
desaturase [14], an enzyme involved in the biosynthesis of
photosynthetic pigments, and α-tocopherol is commonly
known as vitamin E. This key role makes HPPD an impor-
tant target for herbicides. Indeed, the importance of this
enzyme in herbicide development has already been shown
by the inhibition of HPPD activity by different types of
bleaching herbicides [15]. Moreover, in humans, defective
tyrosine degradation causes tyrosinemia, which can be
related to severe mental retardation or minor eye problems
[16]. One of these tyrosine disorders, called type III
tyrosinemia, is a hereditary disease directly related to a
Addresses: 1Institut de Biologie Structurale ‘Jean-
Pierre Ebel’, CNRS/CEA, 41 Avenue des Martyrs,
38027 Grenoble Cedex 1, France, 2Rhône-Poulenc,
secteur Agrochimie, 14–20 rue Pierre Baizet,
69009 Lyon, France, 3Centre de Biophysique
Moléculaire/CNRS, rue Charles Sadron, 45071
Orléans Cedex 2, France and 4Université Joseph
Fourier, BP 53, 38041 Grenoble Cedex 9, France.
†Present address: Centre de Biophysique
Moléculaire/CNRS, rue Charles Sadron, 45071
Orléans Cedex 2, France (affiliated to the
Orléans University).
*Corresponding author.
E-mail: laurence@cnrs-orleans.fr
Key words: crystal, dioxygenase, herbicide,
iron, tyrosinemia
Received: 4 March 1999
Revisions requested: 15 April 1999
Revisions received: 30 April 1999
Accepted: 4 May 1999
Published: 21 July 1999
Structure August 1999, 7:977–988
http://biomednet.com/elecref/0969212600700977
© Elsevier Science Ltd ISSN 0969-2126
Research Article 977
deficiency in HPPD activity. Patients affected by type I
tyrosinemia can be treated with 2-(2-nitro-4-trifluoro-
methylbenzoyl)cyclohexane-1-3-dione (NTBC), an inhibitor
of the HPPD enzyme [17,18]. Such treatment prevents the
biosynthesis of fumarylacetoacetate and of the saturated
derivatives that lead to liver and kidney damage.
In this paper we describe the tetrameric structure of the
Pseudomonas fluorescens HPPD at 2.4 Å resolution. The
HPPD structure displays a similar fold to that of the
Pseudomonas putida catechol 2,3-dioxygenase (also called
metapyrocatechase MPC) [19] and the 2,3-dihydroxy-
biphenyl dioxygenase (DHBD; EC 1.13.11.39) from
Pseudomonas — two extradiol ring cleavage dioxygenases
[20,21] that exhibit less than 20% primary sequence
identity with the P. fluorescens HPPD. A comparison of
these structures shows that there are some important dif-
ferences between the active sites of these enzymes and
allows us to model the interaction of HPPD with its
natural substrates. We believe that this model will help
us to understand the complex chemistry of the HPPD
reaction and aid the design of new HPPD inhibitors for
use in herbicide development.
Results
Quality of the model
The structure of P. fluorescens HPPD was solved from a
thiomersal derivative crystal using the single isomorphous
replacement with anomalous scattering (SIRAS) method.
Because of a higher completeness of the data, the mercury
data set was used to refine the three-dimensional structure.
The final model of HPPD (Rfree 27.6%; R factor 21.9%, cal-
culated with all the reflections between 20.0 and 2.4 Å)
consists of 11,119 nonhydrogen atoms, four iron atoms, four
ethyl mercury (EMC) molecules, four acetate (ACT) mol-
ecules and 482 water molecules. The complete statistics
for each monomer are shown in Table 1. The first three
N-terminal and the last C-terminal residues are disordered
in each monomer. Residues 299–304 are present in a loop
that is poorly defined in the electron-density map for
monomers B, C and D and their occupancies have been set
to 0.00 in the refinement steps. The superimposition of the
Cα atoms between monomers leads to root mean square
(rms) values between 0.2 and 0.4 Å. The rms deviations
from ideal bond lengths and bond angles are 0.008 Å and
2.47°, respectively, for the whole tetramer (X-PLOR geo-
manal analysis [22]). The Ramachandran plot shows that
88.9% of the residues are found in the most favored regions
and 11.1% in the additional allowed regions. A Luzatti plot
gives an estimated error on the coordinates of 0.25 Å.
Three-dimensional topology
The P. fluorescens HPPD structure has an α/β fold with a
core made up of a mixture of parallel and antiparallel
β strands surrounded by α helices. The general structure
consists of two barrel-shaped structural domains (Figure 2).
The N-terminal domain (residues 4–155) is the smaller
domain without any reported catalytic function and contains
at its center the EMC molecule covalently bound to residue
Cys78. The catalytic iron atom of HPPD is found in the 
C-terminal domain (residues 156–355) and the general
topology of each domain is built from two βαβββα modules.
In this paper, the N-terminal domain will be described by
modules I and II and the C-terminal domain by modules III
and IV. Modules II and IV exhibit some variation from the
basic scheme: β strand B2 has disappeared in module II,
which exhibits an additional short β strand (E) that interacts
with β strand B1 of module I. Concerning module IV, a
small α helical subdomain (residues 246–293) is inserted
instead of the single helix present in the basic scheme. The
C-terminal helix H11 closes the C-terminal β barrel and
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Figure 1
Homogentisate biosynthesis. Schematic of the reaction catalyzed by
HPPD.
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Table 1
Statistics for the different monomers.
Monomer A B C D
Polypeptide chain
Number of atoms 2808 2772 2767 2772
Average mainchain B factor (Å2) 27.3 28.7 32.0 30.2
Average sidechain B factor (Å2) 29.5 31.3 34.6 32.5
Water molecules
Number 147 140 138 142
Average B factor (Å2) 32.8 34.2 38.6 37.0
Iron atoms
B factor (Å2) 12.7 18.6 20.8 18.8
Distance (Å) 
Nε2 His240 2.1 2.1 2.1 2.1
Nε2 His161 2.2 2.2 2.2 2.1
Oε1 Glu322 2.0 2.0 2.1 2.0
Oε2 Acetate 2.2 2.2 2.1 2.1
Acetate molecules
Average B factor (Å2) 19.1 21.6 23.0 21.8
Distance (Å) 
Oε1–Wat25 3.2 2.9 2.8 2.7
Oε2–Fe 2.2 2.2 2.1 2.1
Oε1–Fe 2.6 2.7 2.7 2.8
Oε2–Gln309 Nε2 2.9 3.0 3.0 3.1
connects modules III to IV. The detailed secondary struc-
ture composition is described in Figure 2. 
The alignment of the different HPPD sequences shows
that the residue conservation is not equally distributed
along the polypeptide chain (Figure 3). Most of the con-
served residues in all of the known sequences are present
in the C-terminal domain of HPPD and concern residues
facing the inside of the β barrel. No conserved residues are
found on the protein surface. The few residues conserved
in the N-terminal domain are involved in connections
between secondary structure elements that are responsible
for the folding of the polypeptide chain (Figure 3).
The active site
The HPPD active site is buried inside the β barrel of the
C-terminal domain of the enzyme. It is formed by one iron
atom that is coordinated to the sidechains of His161 (Nε2
atom), His240 (Nε2 atom) and Glu322 (Oε1 atom) located
on β strands A3, A4 and D4, respectively. Each atom
involved in the coordination is located 2.0 to 2.2 Å from
the iron atom (Table 1; Figure 4). These distances are
compatible with extended X-ray absorption fine structure
(EXAFS) analysis that showed evidence of Fe–O and
Fe–N bonds with distances between 1.85 and 2.15 Å
(J Jordanov, personal communication). Electron paramag-
netic resonance (EPR) spectroscopy also indicated an
isotropic signal at g = 4.3, characteristic of a high spin
Fe3+ (s = 5/2) (J Jordanov, personal communication). 
A water molecule was first modeled at a distance of 2.4 Å
from the iron atom, on the basis of homology with the
DHBD model [20,21]. But further refinement steps showed
that a molecule of acetate provided from the crystallization
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Figure 2
General topology of P. fluorescens HPPD. (a) Schematic representation
of the secondary structure: β strands are represented as green arrows,
helices as yellow and blue cylinders. The secondary structure elements
were defined according to DSSP criteria [47]. β Strands A1 (residues
10–19), B1 (residues 36–41), C1 (residues 46–51), D1 (residues
54–59), A2 (residues 76–84), C2 (residues 115–117), D2 (residues
123–127), E (residues 141–143), A3 (residues 156–165), B3 (residues
185–193), C3 (residues 198–205), D3 (residues 212–218), A4
(residues 240–245), B4 (residues 294–300), C4 (residues 303–311)
and D4 (residues 320–327); α helices H1 (residues 27–32), H2
(residues 65–73), H3 (residues 87–96), H4 (residues 136–140), H5
(residues 170–182), H6 (residues 225–233), H7 (residues 248–257),
H8 (residues 268–272), H9 (residues 274–277), H10 (residues
285–291) and H11 (residues 334–351). The location of the missing
β strand B2 has been indicated by dashed lines. The three residues
involved in the iron coordination are marked by short arrows. (b) Ribbon
representation of the HPPD tetramer. The iron and mercury atoms are
shown as purple and red spheres, respectively. HPPD-specific helices are
represented as orange cylinders; β strands are in green and helices are in
cyan. (The figure was generated using the program RIBBONS [48].)
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(b)
(a)
                          T................T              TT                   .     
                    1                        10        20           30        40     
P.fluorescens ....................ADLYENP................MGLMGFEFIEFASPTPG...TLEPIFEIMGFTKVA .HRSKN                                                                              T      
HPPD_HUMAN    ..........TTYSDKG....AKPERG..............RFLHFHSVTFWVGNAKQAASFYCSKMGFEPLAYRGLE GSREVV                                                                              T      
HPPD_COCIM    ....MAPAADSPTLQ.....PAQPSD..........LN...QYRGYDHVHWYVGNAKQAATYYVTRMGFERVAYRGLE GSKAVA                                                                              T      
HPPD_DAUCA    MGKKQSEAEILSSNSSNTSPATFKLVGFNNFVRANPKSDHFAVKRFHHIEFWCGDATNTSRRFSWGLGMPLVAKSDLS GNSVHA                                                                              T      
      TT                                                                          TT 
    50        60                            70        80        90       100       110
P.fluorescens VHLYRQGEINLILNNEPN....................SIASYFAAE  PS CGM FR KDSQKAYNRALEL  QPIHIDTGPME                                               HG  V   A  V             GA           
HPPD_HUMAN    SHVIKQGKIVFVLSSALN...............PWNKEMGDH..LVK  DG KDI FE EDCDYIVQKARER  KIMREPWVEQD                                               HG  V   A  V             GA           
HPPD_COCIM    SHVVRNGNITFILTSPLR.SVEQASRFP..EDEALLKEIHAH..LER  DG KDV FE DCVESVFSAAVRN  EVVSDVRTVED                                               HG  V   A  V             GA           
HPPD_DAUCA    SYLVRSANLSFVFTAPYSPSTTT..S.SGSAAIPSFSASGFHSFAAK  LA RAI LE ADVAAAFEASVAR  RPASAPVELDD                                               HG  V   A  V             GA           
                                       TT       TT                                   
            120       130        140        150       160       170       180        
P.fluorescens LN....LPAIKGI GAPLYLIDRFG.E SSIYDIDFVYLEG.VERNPVGAGLKVI  LTH VYRGRMVYWANFYEKLFN REARY             G             G                           DH   N                  F     
HPPD_HUMAN    KFGKVKFAVLQTY DTTHTLVEKMNYI QFLPGYEAPAFMDPLLPKLPKCSLEMI  IVG QPDQEMVSASEWYLKNLQ HRFWS             G             G                           DH   N                  F     
HPPD_COCIM    EDGQIKMATIRTY ETTHTLIERSGYR GFMPGYRMESNADATSKFLPKVVLERI  CVG QDWDEMERVCDYYEKILG HRFWS             G             G                           DH   N                  F     
HPPD_DAUCA    Q...AWLAEVELY DVVLRFVSFGREE LFLPGFEA.VEGTASFPD.LDYGIRRL  AVG VT..ELGPVVEYIKGFTG HEFAE             G             G                           DH   N                  F     
  ...               TT           TT                                                  
190          200       210       220         230       240       250           260    
P.fluorescens FD...IKGEYTG T KAMSAPDGMIRI L  ESSKGAG..  EEFLMQFN E I  V FLTDDLVKTWDALKKI.... MR MTA            L S            P NE         QI        G G QH A                    G  F   
HPPD_HUMAN    VDDTQVHTEYSS R IVVANYEESIKM I  PAPGKKK.S  QEYVDYNG A V  I LKTEDIITAIRHLRER.... LE LSV            L S            P NE         QI        G G QH A                    G  F   
HPPD_COCIM    VDDKDICTEFSA K IVMASPNDIVKM I  PAKGKKQ.S  EEYVDFYN A V  I LRTNNIIDAITNLKAR.... TE IKV            L S            P NE         QI        G G QH A                    G  F   
HPPD_DAUCA    FTAEDVGTLESG N VVLANNEEMVLL L  PVYGTKRKS  QTYLEHNE A V  L LVSEDIFRTLREMRKRSCLG FE MPS            L S            P NE         QI        G G QH A                    G  F   
                                       TT              T..T                          
   270           280       290       300       310         320                       
P.fluorescens  PD   EMLEGRLP....DHG PVDQLQARG  L GSSVEGDKRL   I SETLMG..PV F F   K...............GDP  TYY               E         IL D          LLQ F          F E IQR                  
HPPD_HUMAN     .S   KQLREKLKTAKIKVK NIDALEELK  V YD....EKGY   I TKPVQDRPTL L V   H...............NHP  TYY               E         IL D          LLQ F          F E IQR                  
HPPD_COCIM     .E   EDMKIRLKRQGLVLD DFETLKSLD  I FD....ENGY   L TKHLMDRPTV I I   N...............NFP  TYY               E         IL D          LLQ F          F E IQR                  
HPPD_DAUCA     PP   KNLKNRVG..DVLSD QIKECEDLG  V RD....DQGT   I TKPVGDRPTL I I   VGCMLKDDAGQMYQKGGCP  TYY               E         IL D          LLQ F          F E IQR                  
                 .                                                                   
330       340        350                                                              
P.fluorescens D   E   KA  ESI R.DQVRRGVLT...........                                                GFG GNF  LF   E                      
HPPD_HUMAN    Q   A   NS  KAF E.EQNLRGNLTNMETNGVVPGM                                                GFG GNF  LF   E                      
HPPD_COCIM    S   A   RA  EAI R.EQALRGTLI...........                                                GFG GNF  LF   E                      
HPPD_DAUCA    G   K   SE  KSI EYEKTLEAKQITGSAAA.....                                                GFG GNF  LF   E                      
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Residue conservation. (a) Primary sequence alignment of HPPD from P.
fluorescens, human (HPPD_Human [1–3]), Coccidioides immitis [10]
(HPPD_Cocim), and Daucus carota [9] (HPPD_Dauca). Sequence
identities are highlighted in black. His161, His240 and Glu322 are
marked by triangles and residues of the active-site pocket are indicated
by a small star. Secondary structure elements of P. fluorescens HPPD
have been included in the figure (assigned according to DSSP [47]):
α helices are displayed as squiggles; β strands are rendered as arrows;
TT, β turn; h, the 310 helix. (The figure was generated using SPrit [49].)
(b) Stereoview Cα trace illustrating the distribution of conserved residues
along the polypeptide chain. Residues conserved among the known
HPPD sequences are shown in black ball-and-stick representation. 
buffer was a better candidate. Moreover, the recently solved
MPC structure [19] shows an acetone molecule near its cat-
alytic iron atom, which adds support to our choice. In HPPD,
the two oxygen atoms of the acetate molecule are 2.1 Å and
2.8 Å away from the iron atom, respectively (Table 1;
Figure 4). The coordinating oxygen atom is also involved in
a hydrogen bond with Nε2 of Gln309. In all monomers, the
acetate group is hydrogen bonded to the Nε2 atom of
Gln309 and the water molecule wat25. According to the loca-
tion of these four ligand sites, the coordination geometry of
the iron atom can be described as a distorted tetrahedra.
The use of noncrystallographic symmetry (NSC) restraints
during the refinement led to few variations in the vicinity
of each iron atom. At the end of the refinement process,
however, there was still a high residual peak in the
(mFo–DFc) electron-density map [23] located around the
iron atom of monomer A; the B factor of this iron atom was
also lower than that of the other iron atoms. This residual
density could not be modeled from the present data;
however, this may suggest an incomplete iron saturation of
the crystallized protein.
The surroundings of the HPPD active site are hydropho-
bic. A cavity analysis (using the program VOIDOO [24])
shows that the largest inside cavity corresponds to the
active site. This cavity includes the three iron coordinating
residues (His161, His240 and Glu322), a majority of
hydrophobic residues (Phe190, Leu199, Ala203, Pro214,
Leu307, Phe311, Phe332, Gly333, Phe337 and Leu340)
and a few polar residues (Thr163, Asn216, Gln309 and
Asn336; Figure 5). All of these residues are located on sec-
ondary structure elements: strands A3, B3, C3, D3, C4 and
D4 and the C-terminal α helix H11. Among these residues,
11 are strictly conserved in all of the HPPD sequences
(Leu199, Pro214, Asn216, Leu307, Gln309, Phe311,
Phe332, Gly333, Asn336, Phe337 and Leu340; Figure 3). A
salt bridge between the two conserved residues Asp160
and Arg326 tightens this pocket on one side of the β barrel,
leading to one possible aperture for the entrance of the
substrate. Simultaneously, the sidechain of Arg326 stabi-
lizes the backbone conformation of residue Gly331, one of
the two glycine residues that surround Phe332, a conserved
residue that faces the catalytic iron atom. 
Tetramerization
The HPPD tetramer is made up of four monomers related
by a noncrystallographic 222 symmetry (Figure 2b). An
average of 2600 Å2 surface area is buried by each monomer
on tetramer formation (GRASP) [25].
Both domains of HPPD are involved in tetramerization.
N-terminal–N-terminal domain contacts are dominant and
form the core of the tetramer. Each N-terminal domain is in
contact with the N-terminal domains of two other subunits.
The C-terminal domains interact only with one adjacent
C-terminal domain. No conserved residues are involved in
the intersubunit contacts. The interface between subunits A
and B (or subunits C and D) involves only interdomain con-
tacts of the N-terminal domains. The interacting residues
are located on the regions connecting secondary structure
elements, like the region between β strands B1 and C1,
β strand A2 and helix H3, the loops between β strands B2
and C2 and between β strand D2 and helix H4. These
residues belong mainly to module II. The interactions
between subunits A and C (or subunits B and D) involve
both domains (e.g. residues of helices H2 and H5, and the
regions connecting helix H3 to β strand B2 and helix H6 to β
strand A4). This interface includes mainly hydrogen-bond
type interactions. The interaction between subunits A and
C (or B and D) also involves the stacking of Tyr167 with its
NCS symmetry-related Tyr167. This tyrosine is only con-
served in the enzyme from Pseudomonas strains and is
replaced with a proline in mammalian HPPD, making such
stacking interactions impossible between two monomers.
Comparison with Pseudomonas DHBD structures and with
the P. putida MPC structure
The screening of the three-dimensional structure database
(DALI [26]) shows that P. fluorescens HPPD belongs to the
same structural family as Pseudomonas DHBD [20,21]. (It
should be noted that, for clarity, DHBD is used as a general
term to describe the structure of Pseudomonas cepacia
DHBD and Pseudomonas sp. BphC.) Recently, another
dioxygenase exhibiting a similar fold was also solved — P.
putida MPC [19]. The DHBD and MPC structures are very
similar to each other and are formed by the same repeated
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Figure 4
Electron-density map around the catalytic iron atom. This electron-
density map was calculated with the coefficients (2mFo–DFc)expPHIc
and all the reflections between 20 and 2.4 Å resolution. The first
contour level is 1σ. Iron coordination bonds are shown as dotted
magenta lines; the iron atom is shown as a green sphere. (The figure
was generated using the program O [27].) 
βαβββ module. The superposition of the Cα atoms of each
model with the HPPD structure gives rms deviations of
2.1 Å for 185 paired Cα atoms for DHBD (LSQ option, in
the program O [27]) and 2.1 Å for 173 paired Cα atoms for
MPC. HPPD has a slightly different organization, however,
and its structure results from repeated βαβββα modules
(Figure 2). The additional helices are involved in inter-
monomer contacts (helices H2, H4 and H6) and in sub-
strate binding (helix H11). Similarly, the MPC structure
also exhibits two short C-terminal helices that could be
involved in substrate binding. The alignment of the HPPD
structure with the three-dimensional structures of MPC
and DHBD shows that less than 15% of the superposed
residues are identical. The conserved residues are distrib-
uted throughout the primary sequence but, apart from the
three catalytic residues, are mainly grouped at the
hydrophobic interface between both domains. Among the
conserved residues in the active site, His195, His240 and
Tyr250 in DHDB (equivalent to His199, His246, Tyr255
in MPC) are strictly conserved in the extradiol dioxygenase
family and are superposed with Phe332, Gln309 and
Phe311, respectively, in the HPPD structure.
The N-terminal domains of these three enzymes have no
catalytic activity and their topology is closer than for the
C-terminal domains (Figure 6). In particular, the N-termi-
nal domains of HPPD and MPC contain an equivalent
number of residues. The protruding loop of MPC
(residues 130–139) corresponds to the region connecting
module II to module III, which includes secondary struc-
ture elements specific to HPPD. In MPC, this loop 
contributes to tetramer formation. In the HPPD structure,
however, this corresponding region has a different orienta-
tion and is not involved in intermonomer interactions.
The relative orientations of the two barrels are similar in
all these structures, but the aperture of the catalytic barrel
is larger in DHBD. In MPC, the C-terminal helix covers
the substrate entrance and makes it narrower. 
The active site of HPPD is more buried and has no direct
contacts with the outside of the protein compared to the
active sites of DHBD and MPC. The catalytic site of the
three enzymes involves two histidine residues (His161
and His240 for HPPD, His146 and His210 for DHBD and
His153 and His214 for MPC) and one glutamic acid
residue (Glu322 for HPPD, Glu260 for DHBD and
Glu265 for MPC). The superimposition of the Cα atoms
of these catalytic residues leads to rms deviations of
0.25 Å and 0.20 Å between DHBD and HPPD, and MPC
and HPPD, respectively. However, the catalytic iron
atoms of HPPD and MPC exhibit an unusual tetrahedral
coordination, whereas the coordination geometry of
DHDB was described as a square pyramid. The active
site of all three enzymes is occupied by a crystallization
additive — t-butanol for DHBD, acetone for MPC and
acetate for HPPD (Figure 7) — but only the acetate mol-
ecule in the HPPD structure is close enough to the iron
atom to be coordinated to it. Moreover, the presence of
this acetate molecule prevents the binding of water mol-
ecules in the direct neighborhood of the catalytic metal
atom. The iron atom of HPPD is not coordinated to any
water molecules, as observed for DHBD.
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Figure 5
The active-site pocket. The residues constituting
the active-site pocket were selected using the
program VOIDOO [24]. The salt bridge
between Arg326 and Asp160 is represented as
dotted lines. (The figure was generated using
the program MOLSCRIPT [50].)
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Structure
Despite the lack of sequence identity, the active-site
pockets of these enzymes have a common hydrophobic
character. The main differences between HPPD and
DHBD or MPC arise from the size of the pocket, its
solvent accessibility and the neighborhood of the
iron atom.
Modeling of the HPPD–HPP complex
The structure of DHBD in complex with its substrate,
2,3-dihydroxybiphenyl (DHB), was used to model the
binding of HPP to HPPD. Ten structures of a complex
formed between HPPD and HPP were obtained by the
simulated annealing procedure and superimposed with
the minimized structure of the free enzyme. The residues
that differ most in the ligand-bound form of the enzyme
are Asn216, His240, Phe311, and especially Phe337 and
Leu340. Corresponding rms deviations are less than 0.4 Å
for the backbone atoms and are in the range 0.1–2.0 Å for
sidechain atoms. In the final structure, the initial hydro-
gen-bonding network between the ligand and HPPD is
conserved. The partial energy value between the HPP
molecule and the protein atoms in the binding site (calcu-
lated for a sphere of 10 Å radius centered on the iron
atom) is ~20 kcal mol–1, lower than that of the correspond-
ing acetate molecule plus the three water molecules (wat5,
wat25 and wat88) and the protein atoms in the binding
site of the minimized X-ray structure. 
Discussion
The P. fluorescens HPPD structure is formed by two struc-
tural domains and its active iron atom is buried in the
C-terminal domain of the enzyme coordinated to His161,
His240, Glu322 and one acetate molecule. Therefore, the
coordination geometry of the iron atom can be described
as a distorted tetrahedron, an unusual geometry for an iron
atom. However, no tyrosine residue was found in the prox-
imity of the catalytic iron, as previously predicted by EPR
studies [28]. This is in agreement with earlier suggestions
based on the histidine distribution [12] of the primary
sequence, which predicted that the iron-binding site
would be located in the C-terminal part of the polypeptide
chain. The importance of the C-terminal residues of
HPPD was also confirmed by site-directed mutagenesis:
truncation of the last 14 residues of the C-terminal domain
showed it to have a crucial role in the catalytic activity of
the rat dioxygenase [29]. 
The P. fluorescens HPPD structure belongs to the α/β
protein family and is derived from four βαβββ modules,
the basic fold of this module has already been described
for bleomycin resistance protein [30], human glyoxylase I
[31], Pseudomonas DHBD [20,21], a polychlorobiphenyl
degrading enzyme and, more recently, P. putida MPC —
another extradiol ring cleavage enzyme [19]. Among these
structures, the Pseudomonas DHBD, P. putida MPC and
human glyoxylase I are metalloenzymes and exhibit the
highest score for their Cα atom superimposition with
HPPD. The HPPD metal-binding site can be superim-
posed with the iron-binding site of DHBD and MPC and
with the human glyoxylase I zinc-binding site. 
The HPPD structure also contains four more helices in
addition to the general βαβββ motif. These variations
have an effect on the organization of HPPD, as three of
these additional helices are involved in contacts between
the different monomers. This is reminiscent of the pro-
truding loop specific to the MPC structure that is involved
in the intermolecular contacts.
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Figure 6
Stereoview superposition of the dioxygenase
structures. The Cα backbones of HPPD, 
P. cepacia DHDB and the Pseudomonas
MPC enzymes are shown in black, purple and
green, respectively.
Structure
Comparison with other dioxygenase structures
DHBD is an extradiol ring cleavage type dioxygenase that
converts 2,3-dihydroxybiphenyl (DHB) into 2-hydroxy-6-
oxo-6-phenylhexa-2,4-dienoate. MPC catalyzes the extra-
diol ring cleavage of catechol to form 2-hydroxymuconate
semialdehyde. HPPD does not catalyze any ring cleavage
and catalyzes a more complex reaction involving a decar-
boxylation, a chain rearrangement and a dioxygenation,
but it shares some common features with DHBD and
MPC: a specificity for aromatic substrates; an enzymatic
activity requiring a non-heme ferrous iron; and a depen-
dence on the oligomerization state. The active site of
these enzymes is also similar and is formed by two histi-
dine residues and one glutamate residue that superimpose
perfectly. Moreover, the unusual tetrahedral coordination
geometry of the HPPD iron atom was also previously
described for MPC [19]. These three enzymes are built
from a repeated folding motif suggesting a similar genetic
duplication process for all of them; however, the percent-
age sequence identity between them is low. The superim-
position of the structures shows that the conserved
residues are related to the iron coordination and are
located at the hydrophobic interface between the two
domains. Residues that are conserved between MPC,  or
DHDB, and HPPD are distributed along the primary
sequence, suggesting that if these proteins have evolved
from a common ancestor [32] the divergence process
occurred at an early stage. Moreover, important residues
like His195, His240 and Tyr250 in DHDB (His199,
His246, Tyr255 in MPC), which are strictly conserved in
this extradiol dioxygenase family, are not present in the
active site of HPPD, supporting the idea that HPPD is an
outsider of this dioxygenase family. The sidechain of
His195 in DHBD (His199 in MPC) is located exclusively
in a β bulge in extradiol dioxygenases; when the βαβββ
modules [31] superimposed, His195 of DHBD aligns with
the sidechain of Phe332 located on the C-terminal helix of
HPPD (Figure 7). His195 and His199 were indeed
thought to be involved either in catalysis in DHBD or to
act as an active site base that could attack a hydroxyl group
of the bound substrate in MPC [19,20]. Phe332 cannot
have such properties and this feature could be related to
the differences between the reaction mechanisms of
HPPD and these extradiol dioxygenases. In addition, the
location of Phe332, between two conserved glycines inside
the region connecting β strand D4 and helix H11, should
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Figure 7
Comparison of the dioxygenase active sites.
(a) Stereoview superposition of the active
sites of P. cepacia DHBD (green) and P.
fluorescens HPPD (yellow). (b) Stereoview
superposition of the Pseudomonas MPC
(green) and P. fluorescens HPPD (yellow)
active sites. These residues have been
selected according to a 6 Å radius sphere
centered on the iron atom position. The two
histidines and the tyrosine that are conserved
in MPC and DHBD are labeled as is Gln309
in the HPPD sequence [50]. ACN, acetone;
t-BU, t-butanol.
(a)
(b)
Structure
also confer a particular flexibility to Phe332 that could be
required during the enzymatic reaction.
Substrate binding
To investigate more precisely the reaction mechanism and
to model the binding of HPP to the HPPD active site, we
used the structure of DHBD in complex with its substrate
DHB [21]. The structure of an HPP molecule can easily be
designed from the structure of the DHBD substrate even
though an HPP molecule is more flexible than a DHB mol-
ecule. In HPPD, the iron atom is not completely coordi-
nated as in the free DHBD — three coordination sites are
still vacant. We suggest that, similarly to DHB, the HPP
molecule could interact directly with the catalytic iron atom
through the O8 and O9 atoms, and thus its binding site
would overlap with the binding site of the acetate molecule
found in the free enzyme structure. The sixth free coordi-
nation site would be occupied by an O2 molecule located
closed to the C1 and C8 atoms of HPP, allowing the attack
of these two carbon atoms by O2 and leading to the release
of a CO2 molecule (Figure 8). HPP would interact with
Phe337, Leu340 and Ile344 removing three water mol-
ecules bound in the free enzyme structure (wat5, wat25 and
wat88). At the bottom of this pocket, the hydroxyl group of
HPP could form two hydrogen bonds with Gln225 and/or
Gln239 (Figure 8). In that configuration, the pyruvate part
of the substrate would be located 2.1 Å from the iron atom
and would form two hydrogen bonds with Gln309 and
wat32, a solvent molecule present in the free enzyme.
Gln309 is actually equivalent to His241 in DHBD (His246
in MPC), which is conserved in the active site of all known
extradiol dioxygenases. In the case of DHBD, Tyr250
(Tyr255 in MPC), another residue conserved in this dioxy-
genase family, interacts with the enzyme substrate via a
hydrogen bond (Figure 7). This residue superposes with
Phe311 in HPPD, which cannot be involved in any hydro-
gen bond. From these comparisons, it appears that there are
some important differences in the mode of substrate
binding in HPPD and DHDB, which could be related to
the specific function of these enzymes. Because of the large
aperture of the DHBD active site, the binding of DHB
depends mainly on the diol group. In HPPD, the catalytic
pocket is more isolated from the protein surface and the
interaction of the 4-hydroxyphenyl moiety of the substrate
with the protein contributes greatly to the binding of the
substrate. This configuration would induce some small
rearrangements of the surrounding sidechains of Phe311,
Phe337, Leu340, Asn216 and His240, as suggested by the
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Figure 8
Suggested model of substrate binding in P.
fluorescens HPPD. (a) The HPP molecule (in
dark gray ball-and-stick representation) is
superposed in the active site of the free
enzyme. The potential hydrogen bonds of
HPP with the protein are indicated by dashed
lines. (b) Complete hexagonal coordination of
the iron atom when one HPP molecule and
one O2 molecule are bound in the active site
of HPPD. The putative coordination bonds are
shown (dark gray lines). HPP is in light gray,
the O2 molecule in black and the iron atom is
in dark gray [50].
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Structure
energy minimization modeling. The O2 molecule would be
located in a hydrophobic environment, near Pro214 and
Tyr163 (Figure 8), which superpose with Ala197 and
Val147 in the DHBD structure [21]. 
Oligomerization
The bacterial HPPD structure reveals no clue as to the
necessity of a tetrameric enzyme. Each monomer has an
identical fold and the same active site, and thus we would
expect each monomer to be self-functional. The tetramer
may correspond to a higher stability state. In fact, the two
possible dimers deduced from the noncrystallographic 222
symmetry correspond to buried surface areas of 1180 Å2
and 1670 Å2 by monomer, which leads to a stability reduc-
tion compared to the tetramer. Thus, even if the 222
symmetry of the HPPD tetramer reflects the dimer orga-
nization of the vertebrate or plant enzymes, the eucaryote
dimer should exhibit a different organization. This is sup-
ported by the absence of conserved residues involved in
the interactions between monomers. In the eucaryote
dimer, the reduction in stability could be balanced by the
additional residues (50 or more) that would contribute to
an increased intermonomer contact surface.
Biological implications
In plants and photosynthetic bacteria, the tyrosine degra-
dation pathway is crucial because homogentisate, one of
the reaction products, is a precursor for the biosynthesis
of photosynthetic pigments. Homogentisate is synthesized
from 4-hydroxyphenylpyruvate (HPP) by 4-hydroxy-
phenylpyruvate dioxygenase (HPPD), an enzyme found
in numerous mammals, plants and procaryotes. Its role in
photosynthesis makes HPPD an important target for her-
bicide development. Moreover, in humans, defective tyro-
sine degradation causes tyrosinemia, which can result in
severe mental retardation, minor eye problems [16] and
liver and kidney damage. Patients affected by these disor-
ders are treated with 2-(2-nitro-4-trifluoro-methylben-
zoyl)cyclohexane-1,3-dione (NTBC), an inhibitor of the
HPPD enzyme [17,18]. 
The bacterial HPPD is active as a tetramer and
we report here its crystal structure solved at 2.4 Å 
resolution. Each monomer is made up of two
structural domains and displays a similar fold to the 
2,3-dihydroxybiphenyl dioxygenase (DHBD) and the cat-
echol 2,3-dioxygenase (MPC) — two extradiol ring cleav-
age dioxygenases [19–21]. In HPPD, the active iron is
buried in the structure and is coordinated to His161,
His240 and Glu322 and one acetate molecule. The com-
parison of these structures highlights some structural
differences between HPPD and the two extradiol dioxy-
genases, which could be correlated to their specific activi-
ties. In addition to this result, the comparison of these
three structures was used to model the interaction of
HPPD with its natural substrates. Thus, one HPP and
one O2 molecule would occupy the three vacant coordina-
tion sites present in the free form of the enzyme.
The Pseudomonas fluorescens HPPD structure, and the
suggested model of interaction of HPPD with its substrates,
will help us to understand the complex chemistry of the
HPPD reaction and aid the design of new HPPD inhibitors
for use in herbicide development or tyrosinemia treatment.
Materials and methods
Expression and purification
The HPPD gene of P. fluorescens A32 was isolated and cloned as
described [33]. The HPPD gene was either subcloned in the expression
vector PKK233.2 (Clontech) and then expressed in E. coli K12 DH10B
strain, or subcloned in the expression vector pBRIMES, a broad host
range cloning vector, and expressed in P. fluorescens strain A32.
For the E. coli overexpressed P. fluorescens A32 HPPD, 1 L of rich
medium 2 × YT broth (with carbenicillin at 100 µg/ml to maintain the
plasmid) was inoculated with 1 ml of overnight strain culture and then
kept at 37°C for 16 h. For the P. fluorescens A32 overexpressed
HPPD, 1 L of rich medium 2 × YT broth was inoculated with 1 ml of
overnight strain culture at 28°C on the same medium and kept at 28°C
for 24 h. The medium was centrifuged at 5000 rpm at 4°C for 15 min
and the cells were resuspended in 2 L of minimal medium M63 contain-
ing 5 mM tyrosine with chloramphenicol at 600 µg/ml. The culture was
maintained at 28°C for 48 h. 
The purification of the overexpressed HPPD was performed according
to the following procedure: cultures were centrifuged at 5000 rpm for
15 min. The pellet was washed twice with 9 g/l NaCl, centrifuged at
5000 rpm for 15 min and then resuspended in 7 ml of KKE buffer
(potassium phosphate 10 mM pH 7.5, KCl 50 mM, EDTA 1 mM). The
lysis of the cell was achieved by 15 min sonication and the lysate was
centrifuged at 5000 rpm for 15 min. The supernatant was precipitated
in 60% ammonium acetate and after centrifugation at 14,000 rpm for
15 min, the pellet was re-suspended in 4 ml of 10 mM potassium phos-
phate, pH 7.5. The suspension was dialyzed overnight against the
same buffer. HPPD purification was done by protein chromatography
(FPLC, Pharmacia). The protein extract was loaded onto a EMD-DEAE
column equilibrated with 10 mM potassium phosphate and eluted with
240 mM NaCl. The fractions containing HPPD were pooled and loaded
onto a hydroxylapatite column Biogel HTP-gel (Bio-Rad) equilibrated
with 10 mM potassium phosphate and eluted with 250 mM potassium
phosphate. New fractions containing HPPD were pooled and loaded
onto a Mono Q HR 5/5 column (Pharmacia) equilibrated with 10 mM
potassium phosphate and eluted with 240 mM NaCl. Fractions con-
taining HPPD were pooled, loaded and desalted on a PD10 Sephadex
G25-M column (Pharmacia-Biotech) with 10 mM HEPES. Fractions
containing HPPD were determined at each step by SDS–PAGE (12%
(w/v) acrylamide) and Coomassie R250 blue staining.
The final fraction was concentrated in a 50 K Microsep filtration to
10–13 mg/ml. The protein concentration was measured by the
method of Bradford using a Bio-Rad protein assay reagent with
γ-globulin as standard.
Activity assay
The activity assay was performed according to the protocol described
in [34]. The purified P. fluorescens HPPD has a specific activity of
1 µmol/mg/min; however, there is no evidence that this specific activity
corresponds to a fully active enzyme. Activity assays were done under
reducing conditions. 
Crystallization
The first crystals were obtained with HPPD overexpressed in E. coli. But
prismatic crystals were reproducible only with the enzyme overexpressed
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in P. fluorescens. Initial conditions for HPPD crystals were obtained from
Hampton Research crystal screen I [35]. Small prismatic crystals grew
overnight by the hanging-drop method in 18–25% PEG 4000, 0.2 M
ammonium acetate, 0.1 M trisodium citrate (pH 5.6) at room tempera-
ture. The protein solution concentration was 10–13 mg/ml. After crystals
appeared, they were dissolved in the hanging drops by the addition of
2 µl of water. The same drops were then equilibrated against water for
24 h then re-equilibrated against 20% PEG 4K, 0.2 M ammonium
acetate, 0.1 M trisodium citrate, pH 5.6 at room temperature. This
allowed nucleation control and prevented a high nucleation rate. We
could obtain one or two crystals (sometimes 1 mm long) per drop using
this method. The best crystals diffracted to 3.5 Å on a Rigaku rotating
anode coupled to a MAR research imaging plate. The freezing of crystals
was necessary to collect complete data sets. For the cryoprotection,
HPPD crystals were soaked for a couple of seconds in 27% PEG 4000,
26% glycerol, 0.2 M ammonium acetate, 50 mM trisodium citrate
pH 5.6. An identical process was applied for the data collection with the
heavy-atom derivative crystal.
The P. fluorescens HPPD crystals are orthorhombic with space group
P212121. The corresponding unit-cell parameters at 100K are:
a = 76.60 Å, b = 142.75 Å, c = 159.44 Å.
Data collection and structure determination 
Preliminary X-ray diffraction data were collected on a MAR research
imaging plate of the laboratory. But the final data were collected at
beam line D2AM (ESRF, Grenoble) on a CCD camera at 100K. The
wavelength was λ = 0.91 Å to optimize the anomalous signal of the
mercury. Data were processed with the XDS program [36]. For the
synchrotron data, the different data sets were merged and scaled with
the XSCALE program. The HPPD structure was solved by the SIRAS
method. The derivative crystals were soaked for three days in 2 mM
thiomersal, 25% PEG 4K, 0.2 M ammonium acetate, 0.1 M trisodium
citrate pH 5.6. After scaling the native and derivative data sets
(SCALEIT, CCP4, version 3.0 [37]), isomorphous and anomalous Pat-
terson difference maps clearly showed the presence of four binding
sites for the mercury atoms that could be correlated with the presence
of four cysteine residues per tetramer.
Heavy-atom positions were determined with SHELXS-90 [38] and then
refined with MLPHARE [39] using both isomorphous and anomalous
signals (Table 2). A first set of SIRAS phases was calculated for reflec-
tions between 20 and 2.4 Å resolution. These phases were then
improved using the density modifications implemented in DM of the
CCP4 suite [40] (histogram matching, solvent flattening and density
averaging). The final phases were then used to calculate an electron-
density map suitable for modeling. 
The building of a skeletonized model (Bones; O program [27]) clearly
showed the presence of several secondary structures. The location of
the mercury atoms was helpful to start the atomic model building (using
the program O, version 5.10 [27]). The initial building was done on one
monomer and then the noncrystallographic symmetry was applied to
generate the whole tetramer. The initial Rfree and R factor were 54%
and 56%, respectively. Rfree was calculated with 5% of the whole data
[41]. Geometry of the model was refined with X-PLOR version 3.1 [22]
with data between 8.0 and 2.4 Å considering the NCS restraints. The
refinement procedure started with a simulated annealing process
(2500K) followed by some energy minimization cycles and the B group
refinement. Each residue was described by two B factors, respectively
for sidechain and mainchain atoms. Geometry quality was checked rou-
tinely with PROCHECK [42]. Structure refinement was then done
against the thiomersal derivative data set because of its higher com-
pleteness. The later stages of the refinement were carried out with
REFMAC for data between 20 and 2.4 Å using tight NCS restraints
[43]. The coordination distances of the iron atom were restrained to
2.1 Å and a bulk-solvent correction was applied during the refinement
procedure. Water molecules were added gradually for one monomer
using ARP [44] and then extended to other monomers and included in
the NCS restraints. When the Rfree values stopped decreasing, the
NCS restraints were loosened. The final R factor and Rfree were 21.9%
and 27.6%, respectively, for all the data in this resolution shell.
Molecular modeling
The molecular modeling study was carried out on a SGI R5000 work-
station. Building and calculations were done with Sybyl software
according to the following protocol. First, the hydrogen atoms were
added to the structure of one monomer. Second, the energy minimiza-
tion via the Powell method [45] took place with the following specifica-
tions: Tripos force field [46], 10 Å cut-off distance, Pullmann atomic
charges, implicit solvent and distance-dependent dielectric constant
ε = 4r. Third, the acetate molecule and three water molecules (wat5,
wat25, wat88) bound in the active site were removed and one HPP
molecule was included. Fourth, the ligand and the protein sidechains in
a spherical domain centered on the iron atom and defined by a 10 Å
radius were submitted to ten runs of a 1000K simulated annealing pro-
cedure; five constraints corresponding to the iron coordination bonds
with His161, His240, Glu322 and the oxygen atoms of the HPP mol-
ecule were set in the range 1.8 to 2.3 Å; two additional constraints cor-
responding to the potential hydrogen bonds were set in the range
1.8–2.8 Å between the HPP hydroxyl group and Glu239 (HNε2 atom),
and with Glu225 (Oε1atom). Finally, the best energy structure was
energy minimized without any aggregate and without constraints.
Accession numbers
The atomic coordinates of P. fluorescens HPPD have been deposited
in the Brookhaven Protein Data Bank under the accession code 1cjx.
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